Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Provention Bio Inc (NQ: PRVB ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Apr 26, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Provention Bio Inc < Previous 1 2 3 4 5 6 7 8 Next > 12 Health Care Stocks Moving In Monday's Pre-Market Session November 22, 2021 Gainers iSpecimen (NASDAQ:ISPC) stock rose 31.09% to $6.45 during Monday's pre-market session. The company's market cap stands at $44.9 million. Provention Bio (... Via Benzinga Provention Bio, inc (PRVB) Q3 2021 Earnings Call Transcript November 06, 2021 PRVB earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO November 04, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO August 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline October 31, 2021 Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... Via Benzinga Provention Bio Reveals Early Data For Coxsackievirus B Vaccine Candidate October 26, 2021 Provention Bio Inc (NASDAQ: PRVB) has announced interim results from the PROVENT Phase 1 trial of PRV-101. PRV-101 is a polyvalent inactivated coxsackievirus B (... Via Benzinga Precigen Posts Additional Interim Data From Type 1 Diabetes Trial October 01, 2021 Precigen Inc's (NASDAQ: PGEN) subsidiary Precigen ActoBio has announced additional interim data from Phase 1b/2a study of AG019 ActoBiotics for... Via Benzinga Provention Bio, Inc. (NASDAQ:PRVB) Long Term Investor Notice: Investigation over Possible Wrongdoing September 22, 2021 San Diego, CA -- (SBWIRE) -- 09/22/2021 -- An investigation was announced over possible breaches of fiduciary duties by certain directors of Provention Bio, Inc. Via SBWire Topics Lawsuit Exposures Financial Legal Product Safety Provention Bio, inc (PRVB) Q2 2021 Earnings Call Transcript August 06, 2021 PRVB earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates August 02, 2021 The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi... Via Benzinga The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs August 01, 2021 Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... Via Benzinga Exposures Product Safety PRVB Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Provention Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: July 20, 2021 July 19, 2021 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Provention Bio, Inc. (PRVB) July 16, 2021 From The Law Offices of Frank R. Cruz Via Business Wire Is Provention Bio a Bad News Buy? July 16, 2021 There's a good case this biotech stock is now at least somewhat undervalued. Via The Motley Fool Exposures Product Safety The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix July 11, 2021 Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback... Via Benzinga NASDAQ:PRVB Investor Notice: Deadline on July 20, 2021 in Lawsuit Against Provention Bio, Inc. July 08, 2021 San Diego, CA -- (SBWIRE) -- 07/08/2021 -- The Shareholders Foundation announced that a deadline is coming up on July 20, 2021 in the lawsuit filed for certain investors of Provention Bio, Inc.... Via SBWire Topics Lawsuit Exposures Financial Legal Product Safety Mid-Afternoon Market Update: Dow Tumbles 300 Points; Advaxis Shares Spike Higher July 06, 2021 Toward the end of trading Tuesday, the Dow traded down 0.86% to 34,488.53 while the NASDAQ fell 0.08% to 14,626.98. The S&P also fell, dropping 0.48% to 4,331.47. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities Here's Why Provention Bio Stock Is Diving Today July 06, 2021 The company's latest letter from the FDA wasn't what investors had hoped for. Via The Motley Fool Exposures Product Safety The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test July 08, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:... Via Benzinga Topics Product Recall Exposures COVID-19 Legal Product Safety The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend July 07, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session July 06, 2021 Gainers Advaxis (NASDAQ:ADXS) shares increased by 43.13% to $0.68 during Tuesday's regular session. The current volume of 106.3 million shares is 1084.49% of Advaxis... Via Benzinga 61 Biggest Movers From Yesterday July 07, 2021 Gainers BSQUARE Corporation (NASDAQ: BSQR) shares climbed 77.1% to close at $7.05 on Tuesday on abnormally-high volume. The company’s stock dropped around 10% on Friday.... Via Benzinga Mid-Day Market Update: Gold Rises Over 1%; Provention Bio Shares Plunge July 06, 2021 Midway through trading Tuesday, the Dow traded down 1.09% to 34,408.75 while the NASDAQ rose 0.01% to 14,641.07. The S&P also fell, dropping 0.60% to 4,326.41. The U.S. has... Via Benzinga Topics Stocks Exposures US Equities 42 Stocks Moving In Tuesday's Mid-Day Session July 06, 2021 Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline... Via Benzinga Mid-Morning Market Update: Markets Mostly Lower; ISM Services PMI Falls In June July 06, 2021 Following the market opening Tuesday, the Dow traded down 0.62% to 34,569.49 while the NASDAQ rose 0.19% to 14,667.72. The S&P also fell, dropping 0.27% to 4,340.67. The U.S.... Via Benzinga Topics Stocks Exposures US Equities Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today July 06, 2021 Odonate Therapeutics, Inc. (NASDAQ: ODT), Opthea Limited (NASDAQ: OPT), ALX Oncology Holdings Inc. (NASDAQ: ALXO), Provention Bio, Inc. (NASDAQ: PRVB) and Advaxis, Inc. (NASDAQ:... Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 06, 2021 Tuesday morning, 51 companies reached new 52-week lows. Noteworthy Highlights: China Life Insurance Co (NYSE:LFC) was the largest company by market cap to set a new... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session July 06, 2021 Gainers Advaxis (NASDAQ:ADXS) stock rose 46.9% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $100.9 million. Axcella... Via Benzinga Provention Bio's Teplizumab Application Receives CRL For Type-1 Diabetes; Stock Drops July 06, 2021 The FDA has issued a Complete Response Letter (CRL) to Provention Bio Inc's (NASDAQ: PRVB) teplizumab marketing application seeking approval for the delay... Via Benzinga Exposures Product Safety 28 Stocks Moving in Tuesday's Pre-Market Session July 06, 2021 Gainers Odonate Therapeutics, Inc. (NASDAQ: ODT) shares rose 38.3% to $4.80 in pre-market trading following 13G from Ikarian Capital showing a 5.2% stake in the company. BSQUARE... Via Benzinga < Previous 1 2 3 4 5 6 7 8 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.